Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 111
Issue Date | Title | Author(s) |
Nov-2023 | Pramipexole for the Treatment of Depression: Efficacy and Mechanisms | Browning, Michael; Halahakoon, Don Chamith |
Oct-2023 | Pro-dopaminergic pharmacological interventions for anhedonia in depression: protocol for a living systematic review of human and non-human studies | Ostinelli, Edoardo; Browning, Michael; Cipriani, Andrea; Harmer, Catherine J |
Aug-2023 | Towards precision in the diagnostic profiling of patients: leveraging symptom dynamics in the assessment of major depressive disorder | Ostinelli, Edoardo; Cipriani, Andrea |
Sep-2023 | Cognitive predictors of stress-induced mood malleability in depression | Harmer, Catherine J |
Jul-2023 | Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder | Browning, Michael |
Jul-2023 | Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation | Fazel, Seena |
Apr-2023 | Measuring affect dynamics: An empirical framework | Taquet, Maxime; Medical Trainee |
Jun-2023 | A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression | Browning, Michael; Goodwin, Guy M; McCutcheon, Robert A; Cowen, Philip J |
Jun-2023 | An online experimental medicine trial on the effect of 28-day simvastatin administration on emotional processing, reward learning, working memory and salivary cortisol in healthy volunteers at risk for depression: OxSTEP protocol | Di Giorgi, Riccardo; Cowen, Philip J |
Feb-2023 | Machine learning prediction will be part of future treatment of depression | Harmer, Catherine J |
Mar-2023 | Fifty years on: Serotonin and depression | Cowen, Philip J; Browning, Michael |
Mar-2023 | Predicting Antidepressant Treatment Response Using Functional Brain Controllability Analysis | Godlewska, Beata R |
Oct-2022 | Mortality in psychotic depression: 18-year follow-up study | Fazel, Seena |
Aug-2022 | Statins in depression: a repurposed medical treatment can provide novel insights in mental health | De Giorgi, Riccardo; Cowen, Philip J; Harmer, Catherine J; Medical Trainee |
May-2022 | Acute neural effects of fluoxetine on emotional regulation in depressed adolescents | Capitao, Liliana; Chapman, Robert; Wright, Lucy C; Murphy, Susannah E; James, Anthony; Cowen, Philip J; Harmer, Catherine J |
Jul-2022 | No Association Between Amygdala Responses to Negative Faces and Depressive Symptoms: Cross-Sectional Data from 28,638 Individuals in the UK Biobank Cohort | Harmer, Catherine J; Tamm, Sandra |
Oct-2021 | Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment | Browning, Michael; Harmer, Catherine J |
Jul-2022 | Investigating inflammation in depression in the chronically ill: Theoretical model and perspectives | Bhui, Kamaldeep |
Jul-2022 | Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals | Tomlinson, Anneka; Henshall, Catherine; Cipriani, Andrea; Nurse |
Jun-2022 | Optimal dose of brexpiprazole for augmentation therapy of antidepressant-refractory depression: A systematic review and dose-effect meta-analysis | Ostinelli, Edoardo |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 111